In this patent infringement action between i-Tec Well Soultions,
LLC ("i-Tec") and Peak Completion Technologies, Inc.
("Peak"), the district court issued an unusual order as
the case approached trial. With the case expected to be a jury
trial, both sides were ordered to submit tailored jury
The district court, most likely frustrated by the unintelligible
jury instructions that are frequently submitted in patent cases,
issued an "Order on Confusion." In the "Order on
Confusion," the district court stated that "the parties
must give the court tailored jury instructions written in plain
language if they want a jury trial in October." Thus, the
district court made it clear that it wanted jury instructions that
could be understood by a jury of lay people even in a complex
But the district court also gave its order some significant
teeth. The district court warned that "[a] party that
downloads form instructions will waive its jury." Given the
district court's warning, it is likely that neither of the
parties will look to form jury instructions to satisfy the district
court's directive on creating jury instructions in "plain
language," so we are unlikely to learn whether such an order,
if enforced, would violate a party's Seventh Amendment right to
a jury trial.
What the "Order on Confusion" does demonstrate is that
the form or model jury instructions in patent cases, particularly
those on obviousness, are complex and difficult to understand,
particularly for a lay jury. Creating better more easy to
understand jury instructions would be a benefit to jurors in patent
cases who are already grappling with complex technology and should
be aided--not hindered--by overly technical, legalistic jury
instructions. We will wait and see what the parties submit and
whether there are any follow up orders on confusion in the
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
As set forth in the decision, Mylan's failure to respond to a deficiency letter received from FDA in May 2014 "raise[d] serious questions in the Court's mind as to the viability of Mylan's ANDA product as currently formulated."
In an attempt to provide further guidance and regulation in this area, since April 2012, a growing number of state legislatures in the United States have passed various forms of social media privacy legislation.
Fed Cir affirms judgment upholding the PTO's patent term adjustment calculation. The patentee had filed its original application in 2002, yet the PTO did not take any action until 2006, when it issued a restriction requirement.